Ondansetron Solution
Product Images NDC 17856-0672

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 17856-0672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologics Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (17856 0672 01 Rev. 1 Case Label)

Ondansetron Oral Solution, USP 4 mg per 5 mL label by Atlantic Biologics Corp. The label specifies a dosage delivery of 2 mg per 2.5 mL and packaging of 60 Enfit syringes. It includes storage instructions, expiration date, GTIN barcode, lot and serial number placeholders, and a call to reorder message.*

FDA Label Image

2 (17856 0672 02 Rev. 1 Case Label)

Label for Ondansetron oral solution, USP, 4 mg per 5 mL, delivering 2 mg per 2.5 mL, packaged as 120 Enfit syringes. The product is labeled by Atlantic Biologics Corp. with storage instructions and includes a barcode, lot, expiration, and serial number fields.*

FDA Label Image

3 (17856 0672 03 Rev. 1 Case Label)

Ondansetron oral solution, USP 4 mg per 5 mL in a box label showing it delivers 2 mg per 2.5 mL. The package contains 120 syringes, distributed by Atlantic Biologics Corp. Storage instructions include protecting from light and storing at 20°-25°C with allowed excursions. The label includes a bar code, GTIN, expiration date, and lot number fields.*

FDA Label Image

4 (17856 0672 04 Rev. 1 Case Label)

Label for Ondansetron oral solution USP 4 mg per 5 mL by Atlantic Biologics Corp. The label specifies the dosage strength of 4 mg per 5 mL and package quantity of 72 cups. Storage instructions indicate to protect from light and store between 20°-25°C with permitted excursions. The label includes a barcode, GTIN, expiration date of 10/23/25, and Rx designation for prescription use.*

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical structure of Ondansetron Hydrochloride Dihydrate shown as a molecular diagram illustrating the arrangement of its atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.